Vertical Integration Doesn’t Appear to Lead to Higher Drug Costs in Medicare, HHS OIG Finds
Insurer ownership of pharmacy benefit managers doesn’t appear to increase the cost of drugs in Medicare, though the jury’s still out, according to a new report from the HHS’ Office of the Inspector General. Government investigators analyzed 60 commonly used and high-cost drugs, and found the overall difference in their prices was negligible — less […]
